Aurobindo Recalls Famotidine 40mg Tablets Due to Foreign Tablet Presence
Aurobindo Pharma USA Inc. is recalling 1,296 bottles of Famotidine 40mg tablets because foreign tablets were found in the product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the presence of foreign tablets (including a different dose of the same drug and a different drug entirely) poses a significant risk of serious injury or death due to incorrect medication administration.
Plain-English summary
Aurobindo Pharma USA Inc. is recalling 1,296 bottles of Famotidine Tablets USP 40mg, 1,000-count bottles. The product is prescription-only and was distributed in Texas, California, Georgia, and Pennsylvania. The specific lot affected is P2000467, with an expiration date of 7/2022.
The recall was initiated because foreign tablets, specifically Famotidine 20mg and ibuprofen 400mg, were found in the lot of famotidine 40mg. This contamination presents a risk of patients receiving incorrect medication or dosages.
Consumers who have this product should stop using it and contact their healthcare provider or pharmacist for guidance. The product should be returned to the pharmacy or disposed of according to local regulations.
The recalled product
- Product
- FAMOTIDINE (FAMOTIDINE)
- Brand
- FAMOTIDINE
- Manufacturer
- Aurobindo Pharma USA Inc.
- Category
- Drug — Prescription Drug
- Affected units
- 1,296
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: P2000467
- Exp 7/2022
Distribution
Related recalls
Same brand · FAMOTIDINE
- CriticalFamotidine injection vials recalled after endotoxin results exceeded the limit
FDA (Drugs) · 2025-12-03
- ModerateFamotidine tablets recalled for carton labeling error on strength
FDA (Drugs) · 2023-07-26
- LowHF Acquisition Recalls Famotidine Injection Due to Temperature Abuse
FDA (Drugs) · 2020-07-29
- LowDr. Reddy's Recalls Famotidine Tablets Due to Impurity Failure
FDA (Drugs) · 2017-10-18
- LowLupin Recalls Famotidine Oral Suspension Due to Manufacturing Deviations
FDA (Drugs) · 2017-09-13
Same manufacturer · Aurobindo Pharma USA Inc.
See all →- ModerateDicyclomine Hydrochloride Capsules Recalled for Empty Capsules
FDA (Drugs) · 2026-08-12
- ModerateAmazon Basic Care Acetaminophen 325 mg Tablets Recalled Due to Discoloration
FDA (Drugs) · 2025-06-25
- HighPrescription drug recall: Aurobindo Nebivolol tablets contain excess nitrosamine impurity
FDA (Drugs) · 2024-12-25
- HighFDA Recalls Cinacalcet 30mg Tablets for N-nitroso Impurity
FDA (Drugs) · 2024-12-11
- HighCinacalcet Tablets Recalled for N-Nitroso Impurity Exceeding FDA Safety Limit
FDA (Drugs) · 2024-12-11
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02